Accelerated approval brings Pfizer’s BRAF inhibitor to first-line patientsnews2024-12-20T20:05:59+00:00December 20th, 2024|Endpoints News|
FDA’s Califf predicts Ramaswamy-RFK battle over agencynews2024-12-20T19:20:44+00:00December 20th, 2024|Endpoints News|
Rhythm receives expanded approval for genetic obesity drugnews2024-12-20T19:17:04+00:00December 20th, 2024|Endpoints News|
FDA approves Humacyte’s lab-grown blood vesselsnews2024-12-20T18:53:56+00:00December 20th, 2024|Endpoints News|
Applied Therapeutics CEO steps down after rare disease drug rejectionnews2024-12-20T15:44:47+00:00December 20th, 2024|Endpoints News|
FDA approves Ionis’ treatment for a rare metabolic disordernews2024-12-20T08:36:02+00:00December 20th, 2024|Endpoints News|
FDA rejects Zealand Pharma’s short bowel syndrome drugnews2024-12-19T20:37:45+00:00December 19th, 2024|Endpoints News|
Xcovery nabs first FDA approval for lung cancer drugnews2024-12-19T20:19:55+00:00December 19th, 2024|Endpoints News|
Mesoblast wins long-awaited approval for cell therapynews2024-12-19T20:17:15+00:00December 19th, 2024|Endpoints News|
Payers generally meet drug price watchdog’s ‘fair access’ standards, report saysnews2024-12-19T18:28:30+00:00December 19th, 2024|Endpoints News|
